INCR: Bathi saben saham sajrone rolas wulan pungkasan InterCure Ltd

InterCure Ltd. (INCR) is positioned for growth due to its status as the undisputed favorite in the Israeli medical cannabis sector. This potential is based on expanding pharmacy coverage in Germany and Israel under strict GMP control. The TTM annual earnings per share confirms the trend, with the current level sitting around -1.00. Cost optimization through external logistics and outsourced marketing helps the company adapt flexibly to regulatory changes.

INCR (InterCure Ltd.) riwayat Bathi resik saben saham sajrone patang kuartal pungkasan saka 04.07.2022 nganti 14.11.2026

Canndoc (INCR) - rincian metrik lan laporan keuangan

- kuotasi saiki lan rata-rata prakiraan nilai:

Bagan rega InterCure|INCR - Konsensus nilai wajar

- informasi kapitalisasi pasar:

Nilai pasar INCR|INCR - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data nilai buku modal saham:

Nilai Buku saben Saham InterCure|INCR - Pambiji Buku Bisnis|Rasio Nilai Pasar marang Nilai Buku intercure.co|INCR - Total Aset Bisnis

- data utang lan likuiditas:

Rasio Total Utang marang Ekuitas InterCure Ltd.|INCR - Rasio silihan jangka dawa marang modal|Utang jangka cendhak marang modal Canndoc|INCR - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku INCR|INCR - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan InterCure|Indikator likuiditas cepet intercure.co

- indikator pendapatan resik lan kelipatan nilai:

INCR - Bathi resik|Bathi sing dikarepake InterCure Ltd.|INCR - Nilai perusahaan marang bathi resik|Pangali Forward P/E Canndoc|INCR - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan INCR|INCR - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan InterCure|INCR - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan intercure.co|INCR - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi kanggo taun ngarep InterCure Ltd.

- data total pendapatan lan volume dodolan:

INCR - Volume dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan InterCure Ltd|INCR - Koefisien rega marang pendapatan|Multiplikator Forward P/S InterCure

Analisis dhasar perusahaan:INCR - Canndoc

Conservative capital demands absolute transparency regarding the business's actual earnings per share. This indicator aggregates net income over a rolling year, excluding short-term fluctuations to assess margin sustainability. For InterCure Ltd. (INCR), this is critical, as regulatory compliance costs limit the effects of production scaling. The investor sees the real efficiency of capital net of operating expenses. The current trailing 12-month EPS value objectifies this trend.

Perusahaan pesaing